Power Law company profile

Corvidia

Biotech & Life Sciences · Waltham, United States · Founded 2015 Unicorn

Creating precision therapies by using the science of genomics in new ways

Valuation

$1–2.5B

Latest valuation · 2026

Unlock exact value

Headcount

<100

Current team size

Unlock exact value

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

7 investors on Corvidia's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 1 investor entered at this stage

Sofinnova Partners

Series A 1 investor entered at this stage

Apple Tree Partners

Series B+ 5 investors entered at this stage

Venrock

Fresenius Medical Care

Cormorant Asset Management

MedImmune

Andera Partners

Global footprint

Where Corvidia has talent and traffic

Workforce by country

1 countries with
team presence

🇺🇸 United States100%

1 country shown

Patent intelligence

$11M patent portfolio · 4 active families

Estimated portfolio value

$11M

0.52% of valuation · 28.2× smaller than top peer Acceleron Pharma ($309M)

4 active patent families

Where Corvidia innovates AntagonistPharmacologyInflammationMolecular biologyImmuno suppression

Where Corvidia concentrates vs peers

Each axis is a top-10 topic across Corvidia and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Corvidia

An AI-synthesized read of the highest-engagement posts about Corvidia on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Corvidia on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles